Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells

NATASHA EMMANUEL, KRISTOPHER A. LOFGREN, ESTHER A. PETERSON, DAVID R. MEIER, ERIC H. JUNG and PARAIC A. KENNY
Anticancer Research August 2018, 38 (8) 4435-4441; DOI: https://doi.org/10.21873/anticanres.12745
NATASHA EMMANUEL
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRISTOPHER A. LOFGREN
2Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ESTHER A. PETERSON
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID R. MEIER
2Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIC H. JUNG
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PARAIC A. KENNY
2Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A.
3Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pakenny{at}gundersenhealth.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Mammary specific expression of GATA3335fs in transgenic mice leads to precocious lobuloalveolar development. A. MMTV-GATA3335fs construct with GATA3335fs cloned downstream of the luminal cell-specific MMTV-LTR promoter. B. Expression of GATA3335fs transgenic protein in virgin, pregnant, and lactating mouse mammary glands analyzed by western blot. MCF7 cells, which express this mutant, were used as a positive control. E-cadherin, an epithelial cell marker, was used as a loading control. C. Representative carmine-stained mammary gland whole mounts in metestrus-matched 9 week MMTV-GATA3335fs and littermate wildtype controls. D. The extent of mammary gland development was quantified in 9 week old MMTV-GATA3335fs (n=10) and wild-type (n=11) mice (p<0.0237, Fisher's Exact Test).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    In vitro growth of ZR751 cells expressing ectopic mutant GATA3. 3D culture colony growth of the ZR751 stable cell lines in the absence or presence of 100 nM estradiol. The graph represents quantification of two independent experiments, each normalized to the median colony size in the control cultures at the time of quantification (**p<0.01, ***p<0.001 and ****p<0.0001, Mann-Whitney test). EV, ZR751 cells transfected with empty vector control; 308*, ZR751 cells expressing FLAG-tagged GATA3308*; 335fs, ZR751 cells expressing FLAG-tagged GATA3335fs.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    In vivo growth of ZR751 cells expressing ectopic mutant GATA3. A. Kaplan–Meier curve showing the time to 100 mm3 xenograft tumor volume (*p<0.05, **p<0.01, Log-rank test). B. Comparison of growth rates of ZR751 xenograft tumors. Graph shows tumor volumes and standard error of the mean (n=20 per group, (*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, Student's t-test). EV, ZR751 cells transfected with empty vector control; 308*, ZR751 cells expressing FLAG-tagged GATA3308*; 335fs, ZR751 cells expressing FLAG-tagged GATA3335fs.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 8
August 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells
NATASHA EMMANUEL, KRISTOPHER A. LOFGREN, ESTHER A. PETERSON, DAVID R. MEIER, ERIC H. JUNG, PARAIC A. KENNY
Anticancer Research Aug 2018, 38 (8) 4435-4441; DOI: 10.21873/anticanres.12745

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells
NATASHA EMMANUEL, KRISTOPHER A. LOFGREN, ESTHER A. PETERSON, DAVID R. MEIER, ERIC H. JUNG, PARAIC A. KENNY
Anticancer Research Aug 2018, 38 (8) 4435-4441; DOI: 10.21873/anticanres.12745
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Mammary-specific ectopic expression of mutant human GATA3 did not potentiate medroxyprogesterone acetate-driven mouse mammary tumorigenesis
  • The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ
  • GATA3 mutation disrupts a functional network governed by estrogen receptor, FOXA1 and GATA3
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • GATA3
  • Breast cancer
  • transcription factor
  • mammary gland biology
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire